Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater

LESSONS LEARNED. Panitumumab has no clinical activity in metastatic RAS wild‐type small bowel adenocarcinoma (SBA) and ampullary adenocarcinoma (AAC), possibly due to the foregut and midgut derivation of small bowel and ampulla. These results, along with findings from genomic characterization of SBA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Gulhati, Pat, Raghav, Kanwal, Shroff, Rachna, Varadhachary, Gauri, Javle, Milind, Qiao, Wei, Wang, Huamin, Morris, Jeffrey, Wolff, Robert, Overman, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905687/
https://ncbi.nlm.nih.gov/pubmed/29259073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0568
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados